TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension

Completed · Phase 3

Conditions studied: Ocular Inflammation Associated With Blepharaconjunctivitis

In brief

The purpose of this study is to describe the differences in efficacy between TOBRADEX Ophthalmic Suspension and Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension in the treatment of ocular inflammation and infection associated with blepharaconjunctivitis

Key facts

Study ID

NCT00576251

Run by

Alcon Research

People needed

221

Starts

2007-10-01

Expected to finish

2008-03-01

Last updated by the study team

2010-03-02

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ocular inflammation associated with blepharaconjunctivitis

You may not qualify if…

• ocular allergy
• ocular disorders that would preclude safe administration of test article

Where it is running

• Houston — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.